Hardest trial ahead for SNFs
Providers are now about halfway through what likely will be the most dangerous stage of the coronavirus crisis and must remain strictly vigilant, the former head of the Food and Drug Administration warned operators.
Print Issue: December 2020
Time to write a ‘new playbook,’ Sloan says
Long-term care providers must take charge of their own future and become “catalysts of change” for a better life beyond the coronavirus public health crisis, LeadingAge President and CEO Katie Smith Sloan declared during her group’s online annual meeting and expo in November.
‘Green’ counties receive tests
Nursing homes in areas that have low COVID-19 positivity rates began receiving rapid testing options from the federal government in November.
Alzheimer’s blood test here
A new blood test that can detect the presence of Alzheimer’s brain plaques became the first to hit the commercial market on a wide scale in late October, according to developer C2N Diagnostics.
Medicare pays for C-19 care
The Centers for Medicare & Medicaid Services in mid-November announced that Medicare will cover monoclonal antibody therapy for COVID-19 treatments.
Therapy services may be on chopping block come Jan. 1
Barring a change in direction by the Centers for Medicare & Medicaid Services, nursing home operators will have to slash the amount of therapy services they can offer, starting Jan. 1.
Most using agencies to cover shift gaps
A majority of senior housing and skilled nursing operators were relying on staffing agencies or temporary workers to meet their workforce needs as of mid-November, a provider survey revealed.
60 seconds with … Lane Bowen
Lane Bowen, Executive VP, Chief Strategic Officer, Avalon Health Care
Outbreak risks connected to shared bedrooms, bathrooms
Nursing homes that utilize shared rooms and bathrooms for residents are at a higher risk of experiencing larger and more deadly COVID-19 outbreaks than facilities that house residents mostly in private rooms, a study, whose results appered in the November issue of JAMA Internal Medicine, found.
New arthritis rules: minimize steroid use
The American College of Rheumatology previewed its 2020 Guideline for the Management of Rheumatoid Arthritis in November. New recommendations encourage a step back from steroid use and a move toward biologic and synthetic therapies.
Next post in Print News
